BOSTON SCIENTIFIC CORP (BSX) Fundamental Analysis & Valuation

NYSE:BSX • US1011371077

Current stock price

61.79 USD
+0.51 (+0.83%)
At close:
61.6887 USD
-0.1 (-0.16%)
After Hours:

This BSX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. BSX Profitability Analysis

1.1 Basic Checks

  • In the past year BSX was profitable.
  • BSX had a positive operating cash flow in the past year.
  • In the past 5 years BSX has always been profitable.
  • BSX had a positive operating cash flow in each of the past 5 years.
BSX Yearly Net Income VS EBIT VS OCF VS FCFBSX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

1.2 Ratios

  • With an excellent Return On Assets value of 6.64%, BSX belongs to the best of the industry, outperforming 84.57% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 11.96%, BSX belongs to the top of the industry, outperforming 86.17% of the companies in the same industry.
  • BSX has a Return On Invested Capital of 8.70%. This is amongst the best in the industry. BSX outperforms 85.64% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for BSX is in line with the industry average of 9.40%.
  • The last Return On Invested Capital (8.70%) for BSX is above the 3 year average (7.70%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.64%
ROE 11.96%
ROIC 8.7%
ROA(3y)5.27%
ROA(5y)4.17%
ROE(3y)9.54%
ROE(5y)7.64%
ROIC(3y)7.7%
ROIC(5y)7.08%
BSX Yearly ROA, ROE, ROICBSX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • BSX has a better Profit Margin (14.44%) than 89.89% of its industry peers.
  • In the last couple of years the Profit Margin of BSX has grown nicely.
  • The Operating Margin of BSX (19.92%) is better than 92.02% of its industry peers.
  • BSX's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 69.01%, BSX is in the better half of the industry, outperforming 77.13% of the companies in the same industry.
  • BSX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.92%
PM (TTM) 14.44%
GM 69.01%
OM growth 3Y6.86%
OM growth 5Y16.97%
PM growth 3Y41.81%
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5Y1.13%
BSX Yearly Profit, Operating, Gross MarginsBSX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BSX Health Analysis

2.1 Basic Checks

  • BSX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • BSX has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BSX has more shares outstanding
  • BSX has a better debt/assets ratio than last year.
BSX Yearly Shares OutstandingBSX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B
BSX Yearly Total Debt VS Total AssetsBSX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.2 Solvency

  • An Altman-Z score of 3.87 indicates that BSX is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of BSX (3.87) is better than 72.87% of its industry peers.
  • The Debt to FCF ratio of BSX is 3.13, which is a good value as it means it would take BSX, 3.13 years of fcf income to pay off all of its debts.
  • BSX's Debt to FCF ratio of 3.13 is amongst the best of the industry. BSX outperforms 80.32% of its industry peers.
  • A Debt/Equity ratio of 0.46 indicates that BSX is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.46, BSX is in line with its industry, outperforming 43.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.13
Altman-Z 3.87
ROIC/WACC1.06
WACC8.24%
BSX Yearly LT Debt VS Equity VS FCFBSX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B

2.3 Liquidity

  • A Current Ratio of 1.62 indicates that BSX should not have too much problems paying its short term obligations.
  • BSX's Current ratio of 1.62 is on the low side compared to the rest of the industry. BSX is outperformed by 73.94% of its industry peers.
  • BSX has a Quick Ratio of 1.08. This is a normal value and indicates that BSX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.08, BSX is doing worse than 78.72% of the companies in the same industry.
  • BSX does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.08
BSX Yearly Current Assets VS Current LiabilitesBSX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. BSX Growth Analysis

3.1 Past

  • BSX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.51%, which is quite impressive.
  • BSX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 26.01% yearly.
  • Looking at the last year, BSX shows a quite strong growth in Revenue. The Revenue has grown by 19.88% in the last year.
  • Measured over the past years, BSX shows a quite strong growth in Revenue. The Revenue has been growing by 15.16% on average per year.
EPS 1Y (TTM)21.51%
EPS 3Y20.34%
EPS 5Y26.01%
EPS Q2Q%14.29%
Revenue 1Y (TTM)19.88%
Revenue growth 3Y16.54%
Revenue growth 5Y15.16%
Sales Q2Q%15.9%

3.2 Future

  • BSX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.13% yearly.
  • The Revenue is expected to grow by 10.46% on average over the next years. This is quite good.
EPS Next Y14.33%
EPS Next 2Y13.76%
EPS Next 3Y13.36%
EPS Next 5Y13.13%
Revenue Next Year10.8%
Revenue Next 2Y10.53%
Revenue Next 3Y10.36%
Revenue Next 5Y10.46%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BSX Yearly Revenue VS EstimatesBSX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B
BSX Yearly EPS VS EstimatesBSX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. BSX Valuation Analysis

4.1 Price/Earnings Ratio

  • BSX is valuated rather expensively with a Price/Earnings ratio of 20.26.
  • 79.26% of the companies in the same industry are more expensive than BSX, based on the Price/Earnings ratio.
  • BSX is valuated rather cheaply when we compare the Price/Earnings ratio to 26.78, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 17.72, the valuation of BSX can be described as rather expensive.
  • Based on the Price/Forward Earnings ratio, BSX is valued cheaper than 82.45% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.54, BSX is valued a bit cheaper.
Industry RankSector Rank
PE 20.26
Fwd PE 17.72
BSX Price Earnings VS Forward Price EarningsBSX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BSX indicates a somewhat cheap valuation: BSX is cheaper than 73.94% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BSX indicates a rather cheap valuation: BSX is cheaper than 80.85% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 25.1
EV/EBITDA 18.87
BSX Per share dataBSX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of BSX may justify a higher PE ratio.
  • A more expensive valuation may be justified as BSX's earnings are expected to grow with 13.36% in the coming years.
PEG (NY)1.41
PEG (5Y)0.78
EPS Next 2Y13.76%
EPS Next 3Y13.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BSX Dividend Analysis

5.1 Amount

  • BSX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BSX Fundamentals: All Metrics, Ratios and Statistics

BOSTON SCIENTIFIC CORP

NYSE:BSX (4/10/2026, 8:09:02 PM)

After market: 61.6887 -0.1 (-0.16%)

61.79

+0.51 (+0.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04
Earnings (Next)04-22
Inst Owners94.54%
Inst Owner Change0%
Ins Owners0.16%
Ins Owner Change2.41%
Market Cap91.83B
Revenue(TTM)20.07B
Net Income(TTM)2.90B
Analysts84.88
Price Target103.74 (67.89%)
Short Float %1.72%
Short Ratio1.51
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.84%
Min EPS beat(2)1.62%
Max EPS beat(2)4.06%
EPS beat(4)4
Avg EPS beat(4)4.68%
Min EPS beat(4)1.62%
Max EPS beat(4)10.56%
EPS beat(8)8
Avg EPS beat(8)5.56%
EPS beat(12)12
Avg EPS beat(12)5.7%
EPS beat(16)15
Avg EPS beat(16)4.38%
Revenue beat(2)1
Avg Revenue beat(2)0.04%
Min Revenue beat(2)-0.88%
Max Revenue beat(2)0.96%
Revenue beat(4)3
Avg Revenue beat(4)0.87%
Min Revenue beat(4)-0.88%
Max Revenue beat(4)2.43%
Revenue beat(8)7
Avg Revenue beat(8)1.73%
Revenue beat(12)11
Avg Revenue beat(12)2.08%
Revenue beat(16)13
Avg Revenue beat(16)1.59%
PT rev (1m)-3.17%
PT rev (3m)-18.44%
EPS NQ rev (1m)-0.12%
EPS NQ rev (3m)-0.43%
EPS NY rev (1m)-0.28%
EPS NY rev (3m)-0.43%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-0.48%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)-0.56%
Valuation
Industry RankSector Rank
PE 20.26
Fwd PE 17.72
P/S 4.57
P/FCF 25.1
P/OCF 20.25
P/B 3.79
P/tB N/A
EV/EBITDA 18.87
EPS(TTM)3.05
EY4.94%
EPS(NY)3.49
Fwd EY5.64%
FCF(TTM)2.46
FCFY3.98%
OCF(TTM)3.05
OCFY4.94%
SpS13.51
BVpS16.31
TBVpS-0.72
PEG (NY)1.41
PEG (5Y)0.78
Graham Number33.45
Profitability
Industry RankSector Rank
ROA 6.64%
ROE 11.96%
ROCE 10.46%
ROIC 8.7%
ROICexc 9.17%
ROICexgc 30.32%
OM 19.92%
PM (TTM) 14.44%
GM 69.01%
FCFM 18.22%
ROA(3y)5.27%
ROA(5y)4.17%
ROE(3y)9.54%
ROE(5y)7.64%
ROIC(3y)7.7%
ROIC(5y)7.08%
ROICexc(3y)7.95%
ROICexc(5y)7.36%
ROICexgc(3y)27.25%
ROICexgc(5y)24.65%
ROCE(3y)9.26%
ROCE(5y)8.51%
ROICexgc growth 3Y16.23%
ROICexgc growth 5Y30.87%
ROICexc growth 3Y13.89%
ROICexc growth 5Y25.4%
OM growth 3Y6.86%
OM growth 5Y16.97%
PM growth 3Y41.81%
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5Y1.13%
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.13
Debt/EBITDA 2.08
Cap/Depr 64.04%
Cap/Sales 4.36%
Interest Coverage 12.54
Cash Conversion 84.48%
Profit Quality 126.23%
Current Ratio 1.62
Quick Ratio 1.08
Altman-Z 3.87
F-Score7
WACC8.24%
ROIC/WACC1.06
Cap/Depr(3y)61.91%
Cap/Depr(5y)57.64%
Cap/Sales(3y)4.69%
Cap/Sales(5y)4.67%
Profit Quality(3y)127.68%
Profit Quality(5y)132.57%
High Growth Momentum
Growth
EPS 1Y (TTM)21.51%
EPS 3Y20.34%
EPS 5Y26.01%
EPS Q2Q%14.29%
EPS Next Y14.33%
EPS Next 2Y13.76%
EPS Next 3Y13.36%
EPS Next 5Y13.13%
Revenue 1Y (TTM)19.88%
Revenue growth 3Y16.54%
Revenue growth 5Y15.16%
Sales Q2Q%15.9%
Revenue Next Year10.8%
Revenue Next 2Y10.53%
Revenue Next 3Y10.36%
Revenue Next 5Y10.46%
EBIT growth 1Y30.81%
EBIT growth 3Y24.54%
EBIT growth 5Y34.7%
EBIT Next Year24.39%
EBIT Next 3Y16.29%
EBIT Next 5Y14.81%
FCF growth 1Y38.35%
FCF growth 3Y57.4%
FCF growth 5Y29.98%
OCF growth 1Y32.03%
OCF growth 3Y43.76%
OCF growth 5Y24.63%

BOSTON SCIENTIFIC CORP / BSX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BOSTON SCIENTIFIC CORP (BSX) stock?

ChartMill assigns a fundamental rating of 7 / 10 to BSX.


What is the valuation status for BSX stock?

ChartMill assigns a valuation rating of 6 / 10 to BOSTON SCIENTIFIC CORP (BSX). This can be considered as Fairly Valued.


Can you provide the profitability details for BOSTON SCIENTIFIC CORP?

BOSTON SCIENTIFIC CORP (BSX) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for BSX stock?

The Price/Earnings (PE) ratio for BOSTON SCIENTIFIC CORP (BSX) is 20.26 and the Price/Book (PB) ratio is 3.79.


Can you provide the dividend sustainability for BSX stock?

The dividend rating of BOSTON SCIENTIFIC CORP (BSX) is 0 / 10 and the dividend payout ratio is 0%.